Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Enanta Pharmaceuticals, Inc. , a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that effective April 29,...

Related Keywords

Matthewp Kowalsky , ,Nasdaq ,Enanta Pharmaceuticals Inc ,Enanta Pharmaceuticals ,Compensation Committee ,Enanta Pharmaceutical Board ,Chief Legal Officer ,Stock Incentive ,Stock Incentive Plan ,Nasdaq Listing ,Enanta Pharmaceutical ,Nasdaq Biotechnology Index ,Markets ,